News & Insights

Categories News and Insights

Stay up to date on the latest legal and IP news and insights by Claire Gregg

Latest News by Claire Gregg

Patents

Formulation patents no longer eligible for PTE in Australia

9 December 20254 minute read

Patents

Can infringement be avoided by performing part of a diagnostic method claim in another jurisdiction?

8 December 20253 minute read

Patents

Why you still can’t have your cake and eat it too: “best method” lives on in Australia

5 December 20253 minute read

Patents

What do sex toys and patent law have in common?

20 October 20254 minute read

Patents

Assessing the patentability of computer-implemented inventions in Australia

10 October 20255 minute read

Patents

The emergence of “relevant ranges” and retroactive insufficiency in Australia and the UK

2 October 20258 minute read

Patents

EPO and APO consider “on-sale bar” for patented products

5 September 20257 minute read

Patents

Australian divisional patent “best method” requirement revisited

12 August 20255 minute read

ICT Electronics & Software

Promising signs for protecting digital health and precision medicine inventions in New Zealand

22 July 20253 minute read

Patents

Australia recognises multiple priorities in a single claim

27 June 20255 minute read

Patents

Amgen’s functional antibody claims survive appeal in Australia

1 May 20258 minute read

Patents

Process or result limitations in a product claim not a barrier to PTE in Australia

11 February 20256 minute read

No results found

News & Insights

Latest News by Claire Gregg

Formulation patents no longer eligible for PTE in Australia

Can infringement be avoided by performing part of a diagnostic method claim in another jurisdiction?

Why you still can’t have your cake and eat it too: “best method” lives on in Australia

What do sex toys and patent law have in common?

Assessing the patentability of computer-implemented inventions in Australia

The emergence of “relevant ranges” and retroactive insufficiency in Australia and the UK

EPO and APO consider “on-sale bar” for patented products

Australian divisional patent “best method” requirement revisited

Promising signs for protecting digital health and precision medicine inventions in New Zealand

Australia recognises multiple priorities in a single claim

Amgen’s functional antibody claims survive appeal in Australia

Process or result limitations in a product claim not a barrier to PTE in Australia